Search research articles
Contact Us
Filters
Showing results (61-70 of 87) with videos related to
Page
of 9
Sort By:
Blood
|
July 17, 2008
The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival
Derville O'Shea, Ciarán O'Riain, Claire Taylor, et al.
Blood
|
August 30, 2008
Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy
Carolyn J Owen, Cynthia L Toze, Anna Koochin, et al.
Blood
|
January 15, 2009
Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation
Derville O'Shea, Ciarán O'Riain, Manu Gupta, et al.
Blood
|
October 1, 2011
MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype
Ellen Leich, Alberto Zamo, Heike Horn, et al.
Nature
|
September 10, 2025
Fluctuating DNA methylation tracks cancer evolution at clinical scale
Calum Gabbutt, Martí Duran-Ferrer, Heather E Grant, et al.
British Journal of Haematology
|
February 6, 2007
Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms
Andrew J Davies, Andreas Rosenwald, George Wright, et al.
Blood
|
May 28, 2009
Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations
Ellen Leich, Itziar Salaverria, Silvia Bea, et al.
Leukemia
|
December 18, 2019
Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC/BCL2 double-hit
Francesco Cucco, Sharon Barrans, Chulin Sha, et al.
Nature Metabolism
|
October 4, 2019
Oncogenic Rag GTPase signaling enhances B cell activation and drives follicular lymphoma sensitive to pharmacological inhibition of mTOR
Ana Ortega-Molina, Nerea Deleyto-Seldas, Joaquim Carreras, et al.
Blood
|
March 31, 2021
KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas
James Heward, Lola Konali, Annalisa D'Avola, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 87) with videos related to
Sort By:
Page
of 9
Blood
|
July 17, 2008
The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival
Derville O'Shea, Ciarán O'Riain, Claire Taylor, et al.
Blood
|
August 30, 2008
Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy
Carolyn J Owen, Cynthia L Toze, Anna Koochin, et al.
Blood
|
January 15, 2009
Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation
Derville O'Shea, Ciarán O'Riain, Manu Gupta, et al.
Blood
|
October 1, 2011
MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype
Ellen Leich, Alberto Zamo, Heike Horn, et al.
Nature
|
September 10, 2025
Fluctuating DNA methylation tracks cancer evolution at clinical scale
Calum Gabbutt, Martí Duran-Ferrer, Heather E Grant, et al.
British Journal of Haematology
|
February 6, 2007
Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms
Andrew J Davies, Andreas Rosenwald, George Wright, et al.
Blood
|
May 28, 2009
Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations
Ellen Leich, Itziar Salaverria, Silvia Bea, et al.
Leukemia
|
December 18, 2019
Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC/BCL2 double-hit
Francesco Cucco, Sharon Barrans, Chulin Sha, et al.
Nature Metabolism
|
October 4, 2019
Oncogenic Rag GTPase signaling enhances B cell activation and drives follicular lymphoma sensitive to pharmacological inhibition of mTOR
Ana Ortega-Molina, Nerea Deleyto-Seldas, Joaquim Carreras, et al.
Blood
|
March 31, 2021
KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas
James Heward, Lola Konali, Annalisa D'Avola, et al.
Page
of 9